跳至主要内容
临床试验/NL-OMON53649
NL-OMON53649尚未招募不适用

Safety and feasibility of the use of cryoablation in patients with brain neoplasm - Cryoablation of brain neoplasm

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age >18 years
  • 2. Tumor suspected as glioma (1. Astrocytoma, IDH mutant 2. Oligodendroglioma,
  • IDH-mutant and 1p/19q-codeleted 3. Glioblastoma, IDH-wildtype), meningioma (WHO
  • gr. 1 and gr 2), or brain metastasis based on preliminary diagnosis for which
  • the patient will undergo surgery
  • 3. Supratentorial or infratentorial localization
  • 4. Safe trajectory/trajectories possible for ablation of at least 70% of the
  • tumor, avoiding eloquent structures
  • 5. Karnofsky performance scale 70 or more
  • 6. Sufficient knowledge of the Dutch language to understand the study documents
  • (in the judgement of the attending physician or researcher)
  • 7. Written Informed consent

排除标准

  • 1. <18 years or >80 years
  • 2. Tumor diameter bigger than 10 cm
  • 3. Unsafe trajectory (eloquent structures could be damaged)
  • 4. Pregnancy
  • 5. Contra-indication for general anesthesia

研究者

相似试验